AI Verdict
IBOC has stronger fundamentals based on our AI analysis.
IBOC vs IBO Fundamental Comparison
| Metric | IBOC | IBO |
|---|---|---|
| Revenue | $886.3M | $32,000.0 |
| Net Income | $412.3M | $-11.8M |
| Net Margin | 46.5% | -36,993.8% |
| ROE | 12.7% | -93.9% |
| ROA | 2.5% | -68.0% |
| Current Ratio | N/A | 0.35x |
| Debt/Equity | 0.00x | 0.00x |
| EPS | $6.62 | $-0.38 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
IBOC vs IBO: Frequently Asked Questions
Is IBOC or IBO a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), IBOC has stronger fundamentals. IBOC is rated HOLD (67% confidence) while IBO is rated STRONG SELL (95% confidence). This is not investment advice.
How does IBOC compare to IBO fundamentally?
INTERNATIONAL BANCSHARES CORP has ROE of 12.7% vs IMPACT BIOMEDICAL INC.'s -93.9%. Net margins are 46.5% vs -36,993.8% respectively.
Which stock pays higher dividends, IBOC or IBO?
IBOC has a dividend yield of N/A or no dividend while IBO has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in IBOC or IBO for long term?
For long-term investing, consider that IBOC has HOLD rating with 67% confidence, while IBO has STRONG SELL rating with 95% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about IBOC vs IBO?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For IBOC vs IBO, the AI consensus favors IBOC based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.